MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-06-0006830
Srinija Drugs Private Limited - pharma in Andhra Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.09 Cr
▲ 64% YoY
Net profit · FY 2024
₹94.62 Lakh
Net margin 5%
EBITDA · FY 2024
₹2.31 Cr
EBITDA margin 12.1%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹60 Lakh
Issued & subscribed
Open charges
₹2.44 Cr
Satisfied ₹1.24 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
19
Provident fund records
About Srinija Drugs Private Limited
Data last updated:
Srinija Drugs Private Limited is a private limited company based in Andhra Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 April 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24233AP2000PTC034263. Its GSTIN is 37AAHCS2879R1ZA (Andhra Pradesh).
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹60 Lakh. It is led by directors including Bulli Raju Nekkanti (Managing Director) and Nekkanti Saraswathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P.N.245 Ida Kondapally Vijayawada, Andhra Pradesh, India – 521228.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.09 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹94.62 Lakh (net margin 5%) and EBITDA of ₹2.31 Cr (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 15% over five years.
The company has about 19 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Srinija. As per MCA filings, the company has open charges of ₹2.44 Cr and satisfied charges of ₹1.24 Cr on record. Court records list 7 cases involving the company, including 5 filed by the company and 2 filed against it; 1 case is pending.
Srinija Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-06-0006830). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srinijadrugs.com.
Company details
CIN U24233AP2000PTC034263
Registration Number 034263
Incorporation Date 17 April 2000
ROC Vijayawada
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-06-0006830
Key People
Bulli Raju Nekkanti Managing Director Nekkanti Saraswathi Director Venkata Satyavani Donavalli Director Recognitions & Rankings of Srinija Drugs
Contact details
Srinija Drugs Private Limited's registered office is in Andhra Pradesh. Its website is srinijadrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressP.N.245 Ida Kondapally Vijayawada, Andhra Pradesh, India – 521228
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Srinija Drugs Private Limited, buy the company report.
Comprehensive company report
Srinija Drugs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Srinija Drugs operates one associated brand: Srinija. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides custom synthesis, process development, and manufacturing services for specialized needs. | srinija.com |
Business activity
The main business activity of Srinija Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Srinija Drugs Private Limited, buy the company report.
Financials of Srinija Drugs Private Limited
FY 2025 filings availableSrinija Drugs Private Limited reported revenue of ₹19.09 Cr (up 64% YoY) for FY 2024.
Revenue · FY 2024
₹19.09 Cr ▲ 64%
Net profit · FY 2024
₹94.62 Lakh margin 5%
EBITDA · FY 2024
₹2.31 Cr margin 12.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 64%
3 years · compounded
▲ 16%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 67%
3 years · compounded
▲ 7%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 64% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹94.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | ||||
| Net Profit Margin | 5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Srinija Drugs Private Limited, buy the company report.
Board of directors of Srinija Drugs Private Limited
Srinija Drugs has 6 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nekkanti Saraswathi | Director | 28 Oct 2023 | 3 Years 0 Months | Current |
| Venkata Satyavani Donavalli | Director | 28 Oct 2023 | 3 Years 0 Months | Current |
| Anantha Laxmi Talluri | Director | 28 Oct 2023 | 3 Years 0 Months | Current |
| Laxmanarao Talluri Also directs: Srinija Life Sciences Private Limited | Director | 17 Apr 2000 | 26 Years 6 Months | Current |
| Venkata Ramesh Donavalli Also directs: Srinija Life Sciences Private Limited | Director | 17 Apr 2000 | 26 Years 6 Months | Current |
| Bulli Raju Nekkanti | Managing Director | 17 Apr 2000 | 26 Years 6 Months | Current |
Peer comparison
Srinija Drugs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dr.Jrk's Research and Pharmaceuticals Private Limited | ₹19.15 Cr (FY 2025) | 4.0% | Chennai, Tamil Nadu, India | |||
| Abyss Pharma Private Limited | ₹19.15 Cr (FY 2024) | 7.0% | New Delhi, Delhi, India | |||
| Srinija Drugs Private Limitedthis company | ₹19.09 Cr (FY 2024) | ₹94.62 Lakh | 5% | 64.0% | 19 | Andhra Pradesh, India |
| Omega Biotech Limited | ₹19.07 Cr (FY 2024) | 10.0% | New Delhi, Delhi, India | |||
| Maha Avtar Health Care Private Limited | ₹19.06 Cr (FY 2025) | 43.0% | Delhi, India |
To see the full peer comparison of Srinija Drugs Private Limited, buy the company report.
Auditor
Srinija Drugs Private Limited is audited by SURESH AND BABU for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURESH AND BABU | FY 2023 | 004254S |
Shareholding
The shareholding of Srinija Drugs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Srinija Drugs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.44 Cr
Satisfied charges
₹1.24 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Sep 2014 | 10521262 | Others | ₹2.44 Cr | Open | |
| 12 Aug 2011 | 10302599 | Oriental Bank of Commerce | ₹90 Lakh | Satisfied | |
| 01 Mar 2006 | 90344024 | Indusind Bank | ₹34 Lakh | Satisfied |
To see the full charge records of Srinija Drugs Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Srinija Drugs Private Limited has 7 court cases on record: 5 filed by Srinija Drugs, 2 filed against it. 1 case is pending and 6 are disposed.
Total cases
7
Filed by the company
5
Filed against the company
2
Pending
1
Disposed
6
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 7 | 2 | 1 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Court case (CCC) | Filed by the company against an individual | Pending |
| High Court of Karnataka | Writ petition | Filed by the company against The State of Karnataka | Disposed |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh, and 5 others | Disposed |
| High Court for State of Telangana | Writ petition | Filed by the company against State of Andhra Pradesh, and 5 others | Disposed |
| High Court of Andhra Pradesh | Writ petition | Filed by the company against A.P Electricty Regulatory Commission, and 2 others | Disposed |
To see the full case history of Srinija Drugs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Srinija Drugs Private Limited has 2 MSME Form 1 returns on record between 2019 and 2020, listing 19 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bhagyanagar Chlorides Pvt Ltd | |||
| an individual supplier | |||
| Sanjay Chemicals (India) Private Limited | |||
| GVR Enterprises | |||
| Sayer Chemical Industries |
To see the full MSME payment records of Srinija Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Srinija Drugs Private Limited has a workforce of 19 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
19
Active EPFO establishments
1
Employee growth
-5%
GST
Srinija Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAHCS2879R1ZA | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Srinija Drugs Private Limited, buy the company report.
Recent activity
Srinija Drugs Private Limited has 6 board changes on record since 2000: 6 appointments. The latest: Anantha Laxmi Talluri was appointed as Director on 28 Oct 2023.
AGM
Srinija Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Srinija Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada.
Appointed
Anantha Laxmi Talluri was appointed as Director.
Appointed
Nekkanti Saraswathi was appointed as Director.
Appointed
Venkata Satyavani Donavalli was appointed as Director.
Charges
A charge with Others of Rs. 244.48 Lakh registered on 08 Sep 2014 with Charge ID 10521262 was modified on 28 Oct 2022.
Charges
A charge with Others amounted to Rs. 244.48 Lakh with Charge ID 10521262 was registered on 08 Sep 2014.
Charges
A charge registered on 12 Aug 2011 via Charge ID 10302599 with Oriental Bank Of Commerce was fully satisfied on 04 Sep 2014.
Charges
A charge registered on 01 Mar 2006 via Charge ID 90344024 with Indusind Bank was fully satisfied on 16 Aug 2012.
Charges
A charge with Oriental Bank Of Commerce of Rs. 90.00 Lakh registered on 12 Aug 2011 with Charge ID 10302599 was modified on 30 Aug 2011.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 90.00 Lakh with Charge ID 10302599 was registered on 12 Aug 2011.
Charges
A charge with Indusind Bank of Rs. 34.00 Lakh registered on 01 Mar 2006 with Charge ID 90344024 was modified on 21 Jun 2007.
5 earlier events are in the company report.
Frequently asked questions
Srinija Drugs is an active private limited company based in Andhra Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 April 2000 (26+ years old) and is registered under CIN U24233AP2000PTC034263.
Srinija Drugs has 6 current directors:
- Bulli Raju Nekkanti - Managing Director
- Nekkanti Saraswathi - Director
- Venkata Satyavani Donavalli - Director
- Anantha Laxmi Talluri - Director
- Laxmanarao Talluri - Director
- Venkata Ramesh Donavalli - Director
The latest financial statements of Srinija Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Srinija Drugs is 37AAHCS2879R1ZA, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Srinija Drugs is U24233AP2000PTC034263. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Srinija Drugs has 7 court cases on record: 5 filed by the company and 2 filed against it. 1 is pending.
Srinija Drugs was incorporated on 17 April 2000, making it 26+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Srinija Drugs by revenue are Dr.Jrk's Research and Pharmaceuticals Private Limited, Abyss Pharma Private Limited, Omega Biotech Limited, Maha Avtar Health Care Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anantha Laxmi Talluri was appointed as Director on 28 Oct 2023. Nekkanti Saraswathi was appointed as Director on 28 Oct 2023. Venkata Satyavani Donavalli was appointed as Director on 28 Oct 2023. Srinija Drugs has 6 board changes on record in total.
Yes, Srinija Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-AP-06-0006830).
Srinija Drugs has 2 MSME Form 1 returns on record between 2019 and 2020, listing 19 overdue payments to 8 micro and small suppliers. The latest return was filed on 02 Dec 2020.
Srinija Drugs can be reached through the website srinijadrugs.com. Its registered office is in Andhra Pradesh, India.